help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Correction for Luque et al., Endocrinology 148 (1) 300-309.
Correction for Feng et al., Endocrinology 149 (4) 1505-1513.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Endocrinology Vol. 149, No. 11 5897
Copyright © 2008 by The Endocrine Society

Erratum

In the article "Severity of the Catabolic Condition Differentially Modulates Hypothalamic Expression of Growth Hormone-Releasing Hormone in the Fasted Mouse: Potential Role of Neuropeptide Y and Corticotropin-Releasing Hormone" by Raul M. Luque, Seungjoon Park, and Rhonda D. Kineman (Endocrinology 148:300–309, 2007) the authors report errors in Table 1 on page 301. The corrected tableGo is shown below. The authors regret any inconvenience this error may have caused.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Mouse-specific primers for somatostatin receptor subtypes (SSTR1–5) used for quantitative real-time, RT-PCR

 
In the article "Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Attenuates the Action of Insulin in Hepatocytes" by Feng Feng, Lijun Wang, Nathaniel Albanese, Andrew Holmes, and Pu Xia (Endocrinology 149:1505–1513, 2008), the authors report an error in Fig. 7A. In the bottom panel (Akt blot) of the figure, the middle 3 bands had not been inverted relative to lanes 4–6 in the original gel, as was the case in the upper phosphor-Akt blot. This error did not alter the interpretation of any of the data presented in the figureGo as well as in the text of the article. The authors apologize for this error.


Figure 7
View larger version (28K):
[in this window]
[in a new window]

  		FIG. 7. Effect of NF-{kappa}B on TWEAK-induced inhibition of insulin action. A, Insulin-induced Akt phosphorylation was assessed in Huh7 cells after the indicated treatment in the presence or absence of Bay 11-7082 (5 µM), MG132 (0.5 µM), or vehicle alone; B, Huh7 cells were transfected with p65 or scrambled control siRNAs. After 36 h, cells were pretreated for 2 h with TWEAK followed by insulin (10 nmol/liter) stimulation, and cell lysates were subjected to Western blot assays using antibodies against phospho-Akt (pAkt) (Ser 473), total Akt, or p65. The histograms represent band intensities that were normalized to total Akt levels. Data are expressed as mean ± SD derived from three separate experiments. *, P < 0.01, Bay 11-7082 or MG132-treated vs. vehicle alone (A); *, P < 0.01, p65 siRNA transfected cells vs. the control (B).

 





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals